Exozymes Inc (EXOZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 3,039 | 9,719 | 67 |
| Receivables | 517 | 737 | 882 |
| TOTAL | $3,940 | $10,820 | $1,214 |
| Non-Current Assets | |||
| PPE Net | 764 | 882 | 753 |
| Other Non-Current Assets | 1,268 | 1,332 | 1,592 |
| TOTAL | $2,032 | $2,214 | $2,345 |
| Total Assets | $5,972 | $13,034 | $3,559 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,241 | 1,103 | 1,148 |
| Other current liabilities | N/A | N/A | 1,000 |
| TOTAL | $1,567 | $1,333 | $2,415 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 853 | 1,157 | 1,387 |
| TOTAL | $1,007 | $1,280 | $1,528 |
| Total Liabilities | $2,574 | $2,614 | $3,943 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 8,479 | 8,368 | N/A |
| Retained earnings | -21,105 | -11,946 | -6,085 |
| TOTAL | $3,397 | $10,421 | $-384 |
| Total Liabilities And Equity | $5,972 | $13,034 | $3,559 |